Since the original observation that mice maintained on a diet of cheese or given daily injections of nutrose (sodium caseinate) are susceptible to amyloid disease (1), the casein model has been used to study the pathogenesis of this disorder. Nevertheless, despite the reproducibility of amyloid induction in mice, guinea pigs, rabbits, and even chickens after multiple casein injections (2), the chemical composition of the amyloid substance in these species is not known nor is it certain whether the changes in their tissues represent a primary or secondary form of anayloidosis.
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BRIEF DEFINITIVE REPORT sequence degradation was converted to its free amino acid by hydrolysis in 57% hydriotic acid (Fisher Scientific Co., Pittsburgh, Pa.) at 125°C for 20 h and the identity confirmed by amino acid analysis (7) .
Sequence Studies.--4.3 mg of peak 4 were dissolved in 0.6 ml of 10% acetic acid and sequenced according to the method of Edman and Begg (8) on a Beckman Sequencer Model 890C (Beckman Instruments, Inc., Fullerton, Calif.). The PTH amino acid residues were identified on a Beckman 65 gas chromatograph (9) .
RESULTS
At the end of the 5-mo injection period the guinea pig spleens were markedly infiltrated with amyloid. Gel chromatography of the isolated fibrils which dissolved in 4 M guanidine (Fig. 1 ) revealed a void volume peak and four retarded peaks. The major retarded peak, peak 4, represented 25 % of the recovered material. Peak 5 could not be separated from the guanidine on a P2 desalting column.
Amino acid analyses of the starting fibrils, the residue after guanidine extraction, and each of the first three peaks showed a marked similarity in composition (Table I) . However, differences were found in the composition of peak 4 which had a greater arginine, aspartic acid, and alanine content and decreased amounts of threonine, proline, cystine, valine, and leucine.
Sequence studies on the guinea pig peak 4 confirmed its homology with the A protein of secondary amyloid with the exception of a 5-residue N-terminal peptide, His-Ala-Lys-Gly-Glu, preceding the usually reported human N-terminal peptide Arg-Ser- (Table II) (4, 5) . There was a substitution of isoleucine FIO. 1. Gel chromatography of guinea pig amyloid fibrils through Sepharose 6B (2.5 cm x 90 cm) eluted with 4 M guanidine HC1, pH 7.5, and collected in 3-ml fractions. His-Ala-Lys-Gly-G lu-Arg-Ser-Ile-Phe-SerArg-Ser-Phe-Phe-Ser Arg-Ser-Trp-Phe-SerHis-Ala-Asp-Leu-( )-Thr-Lys-Val-Phe-Val- Antiserum prepared in rabbits to the guanidine-denatured guinea pig amyloid fibrils gave a single precipitin line when tested by double diffusion in agar against the guanidine-denatured fibrils or the isolated peak 4 material (Fig. 2) . The antiserum also detected a cross-reacting substance in amyloidotic guinea 874 SKINNER ET. AL. pig serum which showed complete identify to the isolated peak 4 protein. The antiserum to guinea pig A protein gave no reaction with human A protein or amyloidotic human serum. Conversely, antiserum to human A protein did not react with guinea pig A protein nor with amyloidotic guinea pig serum. The presence of weak precipitin lines against antiserum to guanidine-denatured guinea pig fibrils identified trace amounts of A protein in the chromatographed peaks 1, 2, and 3.
BRIEF DEFINITIVE REPORT n FIO. 2(a). Double-diffusion analysis of antiserum to denatured amyloid fibrils of guinea pig origin (anti-GP A) vs. guinea pig P-component (GP P), amyMdotic serum (GP S), and isolated A protein (GP A) showing complete identity between guinea pig A protein and a component in guinea pig serum. No reaction is noted with human A protein (H A), serum (H S) or P component (H P). (b) Double-diffusion analysis of antiserum to
DISCUSSION
In this study, sequence analysis of experimentally induced guinea pig amyloid fibrils has revealed the secondary (A protein, nonimmunoglobulin) nature of these fibrils when compared to the known sequences of the human A protein (Table II) . Amyloid associated with chronic granulomatous disease in monkeys has also been shown to contain the unique A protein sequence (Table II) (4, 10) .
Deletions in the first one, two, or three amino acids, Arg-Ser-Phe, of A protein have been noted in the human A protein sequence. The current study demonstrates an additional N-terminal peptide (His-Ala-Lys-Gly-Glu) in the guinea pig. While the significance of this finding is not known, it has been suggested that A protein might be derived by proteolysis of a larger protein because of 875 individual N-terminal variations. Also, the demonstration of a guinea pig serum factor immunologically identical with the A protein is consistent with a circulating precursor of the amyloid fibrils.
When the N-terminal sequence of A protein from human and monkey amyloid are compared, substitutions are noted in two positions, 3 and 11. As might be expected phylogenetically, more substitutions, a total of five, are found when the guinea pig and human A protein are compared. In terms of the nucleotide interchange for the codon of the amino acids two of these, positions 3 and 14, represent first base changes and three of these, positions 8, 11, and 18, represent second base changes. Equal amounts of serine and alanine at positions 10 and 20 is thought to be individual variations found in this study since the sample consisted of pooled guinea pig spleens.
We have previously noted the sequence beginning His-Ala in the amyloidassociated protein, human P component (Table II) (11) , but this sequence to 23 residues is not homologous with A protein. P component is a minor constituent of amyloid tissues, and is antigenically identical to a plasma alpha globulin found in both normal and amyloidotic subjects (12) . Neither human nor guinea pig P components react with either human or guinea pig antisera to A protein (Fig. 2) . In conclusion, the present study not only provides a definitive Nterminal sequence analysis of experimental anayloid fibrils, but chemically verifies their relationship to secondary amyloid.
SUMMARY
Amyloidosis was produced experimentally in guinea pigs by multiple casein injections. Amyloid fibrils were isolated and fractionated and a protein obtained that had an amino acid composition comparable with A protein, a unique nonimmunoglobulin constituent of secondary amyloid deposits. N-terminal sequence analysis demonstrated a sequence homologous with that of A proteins from human and monkey preparations but preceded by a 5-residue peptide which had an N-terminal histidine. A definite species specificity in A protein from human and guinea pig was identified on immunologic analysis.
